Attention deficit hyperactivity disorder (ADHD) and the dopamine D4 receptor gene: Evidence of association but no linkage in a UK sample

Molecular Psychiatry

Volumn 6, Issue 4, 2001, Pages 440-444

  Mill, J ^a   Curran, S ^a   Kent, L ^b   Richards, S ^a   Gould, A ^a   Virdee, V ^a   Huckett, L ^a   Sharp, J ^a   Batten, C ^a   Fernando, S ^a   Simanoff, E ^c   Thompson, M ^d   Zhao, J ^a   Sham, P ^a   Taylor, E ^a   Asherson, P ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d Ashurst Hospital   (United Kingdom)

Author keywords

ADHD; DRD4; Genetic association

Indexed keywords

DOPAMINE 4 RECEPTOR;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CONTROLLED STUDY; FAMILY STUDY; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; TANDEM REPEAT; UNITED KINGDOM;

ALLELES; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CASE-CONTROL STUDIES; CHILD; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXONS; FALSE POSITIVE REACTIONS; FEMALE; GENE FREQUENCY; GENOTYPE; GREAT BRITAIN; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MINISATELLITE REPEATS; PARENTS; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D4; REPRODUCIBILITY OF RESULTS; RISK; SOFTWARE;

EID: 0034979209     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000881     Document Type: Article

References (30)

1. Mission: Not impossible? Candidate gene studies in child psychiatric disorders
2. A generalization of the transmission/disequilibrium test for uncertain-haplotype transmission
3. Dopamine D4 gene 7-repeat allele and attention deficit hyperactivity disorder
4. Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): A family-based approach
5. Evidence that the dopamine D4 receptor is a susceptibility gene in attention deficit hyperactivity disorder
6. Dopamine DRD4 receptor polymorphism and attention deficit hyperactivity disorder
7. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder
8. Association and linkage of DRD4 and DRD5 with attention deficit hyperactivity disorder (ADHD) in a sample of Turkish children
9. Adult attention deficit hyperactivity disorder and the dopamine D4 receptor gene
10. A family-based and case control association study of the dopamine D4 receptor gene and dopamine transporter gene in attention deficit hyperactivity disorder
11. Lack of an association between a dopamine-4 receptor polymorphism and attention-deficit/hyperactivity disorder: Genetic and brain morphometric analyses
12. No association of the dopamine DRD4 receptor (DRD4) gene polymorphism with attention deficit hyperactivity disorder (ADHD) in the Irish population
13. A haplotype relative risk study of the dopamine D4 receptor (DRD4) exon III repeat polymorphism and attention deficit hyperactivity disorder (ADHD)
14. Failure to replicate an excess of the long dopamine D4 exon III repeat polymorphism in ADHD in a family-based study
15. No evidence of association between dopamine D4 receptor variants and bipolar affective disorder
16. Repeat length variation in the dopamine D4 receptor gene shows no evidence of association with schizophrenia
17. Association mapping in structured populations
18. Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results
19. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants
20. Selective reconstitution of human D4 dopamine receptor variants with Gi alpha subtypes
21. Comparative pharmacological and functional analysis of the human dopamine D4.2 and D4.10 receptor variants
22. Identification of a polymorphism in the promoter region of DRD4 associated with the human novelty seeking personality trait
23. A test-retest reliability study of child-reported psychiatric symptoms and diagnoses using the Child and Adolescent Psychiatric Assessment (CAPA-C)
24. Hypescheme: An operational criteria checklist and minimum data set for molecular genetic studies of attention deficit and hyperactivity disorders
25. Autism screening questionnaire: Diagnostic validity
26. The strengths and difficulties questionnaire: A research note